Skip to main content

MARSHALL WACE, LLP

Position in OCUL — Ocular Therapeutix, Inc

CIK 1318757 LONDON, X0

Position in OCUL

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,237,643
-$5,036,958 QoQ
Shares Held
126,033
-83.0% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#93
of 257 holders
Holding Since
Mar 2020
11 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in OCUL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $3,014,740,742 across 267 Biotechnology names. OCUL ranks #168 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in OCUL

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,237,643 126,033
2026-03-31 $6,274,601 740,803
2025-12-31 $16,719,243 1,377,203
2025-09-30 $18,720,937 1,601,449
2024-09-30 $763,364 87,743
2024-06-30 $2,938,409 429,592
2023-06-30 $78,168 15,149
2022-09-30 $2,206,289 531,636
2021-09-30 $893,350 89,335
2021-06-30 $185,956 13,114
2020-03-31 $161,038 32,533